Neuropathology of diabetic neuropathy and its correlations with neurophysiology

Clinical Neuroscience

Volumn 4, Issue 6, 1997, Pages 359-364

  Sima, Anders A F ^a   Varghese Cherian, P ^b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Diabetes; Electrophysiology; Neuropathy; Pathology

Indexed keywords

NEUROTROPHIC FACTOR; POLYOL;

DEMYELINATION; DIABETIC NEUROPATHY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NERVE BIOPSY; NERVE REGENERATION; NEUROPATHOLOGY; NEUROPHYSIOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW;

AXONS; DEMYELINATING DISEASES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; DISEASE PROGRESSION; HUMANS; NERVE FIBERS; NERVE REGENERATION;

EID: 0030668282     PISSN: 10656766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Baba M, Kashiwamura H, Yagihashi S, Matsunaga M (1994): Coexistence of chronic inflammatory demyelinating polyneuropathy in diabetes mellitus. Int J Diab 2:39-44.
2. Behse F, Buchtal F, Carlsen F (1977): Nerve biopsy and conduction studies in diabetic neuropathy. J Neurol Neurosurg Psychiatry 40:1072-1082.
3. Bischoff A (1968): Diabetische Neuropathie. Pathologische Anatomie, Pathophysiologie ind Pathogenese auf Grund Electronenmikroskopische Untersuchungen. Dtsch Med Wochenschr 93:237-241.
4. Bradley J, Thomas PK, King RHM, Llewlyn JG, Muddle JR, Watkins PJ (1990): Morphometry of endoneurial capillaries in diabetic sensory and autonomic neuropathy. Diabetologia 33:611-618.
5. Brismar T, Sima AAF (1981): Changes in nodal function in nerve fibers of the spontaneously diabetic BB-Wistar rat. Potential clamp analysis. Acta Physiol Scand 113:499-506.
6. Britland ST, Young RJ, Sharma AK, Clarke BF (1990): Relationship of endoneurial capillary abnormalities to type and severity of diabetic polyneuropathy. Diabetes 39:909-913.
7. Cameron NE, Cotter MA (1994): The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications. Diabetes Metab Rev 10:189-224.
8. +-channel displacement is associated with nerve conduction slowing in the chronically diabetic BB/W-rat. Prevention by an aldose reductase inhibitor. J Diab Compl 10:192-200.
9. Chopra JS, Hurwitz LJ, Montgomery DAD (1969): The pathogenesis of sural nerve changes in diabetes mellitus. Brain 92: 391-118.
10. Cornblath DR, Drachman DB, Griffin JW (1987): Demyelinating motor neuropathy in patients with diabetic polyneuropathy. Ann Neurol 22:126-132.
11. Diabetes Control and Complication Trial Research Group (1993): The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med 329:977-986.
12. Dyck PJ, Hansen S, Karnes J, O'Brien P, Yasuda H, Windebank A, Zimmerman B (1985): Capillary number and percentage closed in human diabetic sural nerve. Proc Natl Acad Sci USA 82:2513-2517.
13. Fagerberg SE (1959): Diabetic neuropathy: A clinical and histological study on the significance of vascular affections. Acta Med Scand 164: Suppl 345, 1-97.
14. Giannini C, Dyck PJ (1994): Ultrastructural morphometric abnormalities of sural nerve endoneurial microvessels in diabetes mellitus. Ann Neurol 36:408-415.
15. Greene DA, Sima AAF, Albers JW, Pfeifer MA (1990): Diabetic neuropathy. In Rifkin H, Porte DP Jr (eds): Diabetes Mellitus, Theory and Practice. 4th ed. New York: Elsevier, pp 710-755.
16. Greene DA, Sima AAF, Stevens MJ, Feldman EL, Killen PD, Henry DN, Thomas T, Dananberg J, Lattimer SA (1993): Aldose reductase inhibitors: An approach to the treatment of diabetic nerve damage. Diabetes Metab Rev 9:189-217.
17. Inoue S, Yajima Y, Sano T, Suzuki S, Sakai H (1990): Effects of prostaglandin E1 on diabetic neuropathy. In Ward JD, Goto Y (eds): Diabetic Neuropathy. Chichester: John Wiley, pp 511-516.
18. Malik RA, Veves A, Masson EA, Sharma AK, Ah-See AK, Schady W, Lye RH, Boulton AJM (1992): Endoneurial capillary abnormalities in mild human diabetic neuropathy. J Neurol Neurosurg Psychiatry 55:557-561.
19. Malik RA, Tesfaye S, Thompson SD, Veves A, Sharma AK, Boulton AJM, Ward JD (1993): Endoneurial localization of microvascular damage in human diabetic neuropathy. Diabetologia 36:454-459.
20. Pirart J (1978): Diabetes mellitus and its degenerative correlations: A prospective study of 4400 patients observed. Diab Care 1:168-188.
21. Ristic H, Sima AAF (1995): Impaired functional maturation of regenerated fibers in diabetic neuropathy is not corrected by ARI-treatment. Diabetologia 38: A233.
22. Sima AAF, Bouchier M, Christensen H (1983): Axonal atrophy in sensory nerves of the diabetic BB-Wistar rat, a possible early correlate of human diabetic neuropathy. Ann Neurol 14:183-188.
23. Sima AAF, Brismar T (1985): Reversible diabetic nerve dysfunction. Structural correlates to electrophysiological abnormalities. Ann Neurol 18:21-29.
24. Sima AAF, Lattimer SA, Yagihashi S, Greene DA (1986): "Axo-glial dysjunction": A novel structural lesion that accounts for poorly reversible slowing of nerve conduction in the spontaneously diabetic BB-rat. J Clin Invest 77:474-484.
25. Sima AAF, Yagihashi S (1986): Distal central axonopathy in the spontaneously diabetic BB-Wistar rat. A sequential ultrastructural and morphometric study. Diab Res Clin Prac 1:289-298.
26. Sima AAF, Bril V, Nathaniel V, McEwen TAJ, Brown M, Lattimer SA, Greene DA (1988a): Regeneration and repair of myelinated fibers in sural nerve biopsies from patients with diabetic neuropathy treated with an aldose reductase inhibitor. N Engl J Med 319:548-555.
27. Sima AAF, Nathaniel V, Bril V, McEwen TAJ, Greene DA (1988b): Histopathological heterogeneity of neuropathy in insulin-dependent and non-insulin-dependent diabetes and demonstration of axo-glial dysjunction in human diabetic neuropathy. J Clin Invest 81:349-364.
28. Sima AAF, Prashar A, Zhang W-X, Chakrabarti S, Greene DA (1990): Preventive effect of long term aldose reductase inhibition (Ponalrestat) on nerve conduction and sural nerve structure in the spontaneously diabetic BB-rat. J Clin Invest 85:1410-1420.
29. Sima AAF (1991): Diabetic neuropathy. In Tze WJ, Sima AAF (eds): Insulin Dependent Diabetes Mellitus; Current Concepts and Approaches. Montreal, Rador Publ., pp 233-244.
30. Sima AAF, Nathaniel V, Prashar A, Bril V, Greene DA (1991): Endoneurial microvessels in human diabetic neuropathy: Endothelial cell dysjunction and lack of treatment effect by aldose reductase inhibitor. Diabetes 40:1090-1099.
31. Sima AAF, Brown MB, Prashar A, Chakrabarti S, Laudadio C, Greene DA (1992): The reproducibility and sensitivity of sural nerve morphometry in the assessment of diabetic peripheral polyneuropathy. Diabetologia 35:560-569.
32. Sima AAF (1992): Structural-functional interactions in the therapeutic response of diabetic neuropathy. J Diab Compl 6: 40-44.
33. Sima AAF, Prashar A, Nathaniel V, Bril V, Werb MR, Greene DA (1993a): Overt diabetic neuropathy: Repair of axo-glial dysjunction and axonal atrophy by aldose reductase inhibition and its correlation to improvement in nerve conduction velocity. Diab Med 10:115-121.
34. Sima AF, Greene DA, Brown MB, Hohman TC, Hicks D, Graepel GJ, Bochenek WJ, Beg M, Gonen B, and the Tolrestat Study Group (1993b): Effect of hyperglycemia and the aldose reductase inhibitor tolrestat on sural nerve biochemistry and morphometry in advanced diabetic peripheral polyneuropathy. J Diab Compl 7:157-169.
35. Sima AAF (1993): Diabetic neuropathy: Pathogenesis, natural history and therapeutic potentials. In Vasselli JR, Maggio CA, Scriabine A (eds): Drugs in Development, Vol. I, A-Glucosidase Inhibition: Potential Use in Diabetes. Bradford, CT: Neva Press, pp 201-209.
36. Sima AAF, Albers JW, Cherian PV, Greene DA, Hohman TC, Beg M, and the Tolrestat Study Group (1993c): Correlations between structure and function in sural nerve biopsies from 336 diabetic patients. Diabetologia 36:A73.
37. Sima AAF (1994): Pathological definition and evaluation of diabetic neuropathy and clinical correlations. Can J Neurol Sci 21: Supple 4, S13-S17.
38. Sima AAF, Ristic H, Merry A, Kamijo M, Lattimer SA, Stevens MJ (1996): Primary preventive and secondary interventionary effects of acetyl-L-carnitine on diabetic neuropathy in the bio-breeding Worcester rat. J Clin Invest 97:1900-1907.
39. Sima AAF (1996): Metabolic alterations of peripheral nerve in diabetes. Sem Neurol 16:129-138.
40. Sugimura K, Dyck PJ (1982): Multifocal fiber loss in proximal sciatic nerve in symmetrical distal diabetic neuropathy. J Neurol Sci 53:501-509.
41. Thomas PK, Lascelles RG (1965): Schwann cell abnormalities in diabetic neuropathy. Lancet i:1355-1356.
42. Thomas PK, Lascelles RG (1966): The pathology of diabetic neuropathy. Q J Med 35:489-509.
43. Vinik AI, Liuzze FJ, Holland MT, Stausberry KB, Le Beau JM, Colen LB (1992): Diabetic neuropathies. Diab Care 15: 1926-1975.
44. Williams E, Timperley WR, Ward JD, Duckworth T (1980): Electron microscopical studies of vessels in diabetic peripheral neuropathy. J Clin Pathol 33:472-480.
45. Williamson JR, Tilton RG, Chang K, Kilo C (1988): Basement membrane abnormalities in diabetes mellitus: Relationship to clinical microangiopathy. Diabetes Metab Rev 4:339-370.
46. Yagihashi S (1995): Pathology and pathogenetic mechanisms of diabetic neuropathy. Diabetes Metab Rev 11:193-225.
47. Yagihashi S, Matsunaga M (1979): Ultrastructural pathology of human diabetic neuropathy. Tohoku J Exp Med 192:357-366.
48. Yasuda H, Dyck PJ (1987): Abnormalities of endoneurial microvessels and sural nerve pathology in diabetic neuropathy. Neurology 37:20-28.
49. Young MJ, Veves A, Walker MG, Boulton AJM (1992): Correlations between nerve function and tissue oxygenation in diabetic patients: Further clues to the etiology of diabetic neuropathy? Diabetologia 35:1146-1150.